Providing market intelligence for more than 35 years

In The News

Amazon dumps rival Apple and Google streaming devices

Amazon.com has announced it will end the sale of Apple TV and Google Chromecast video-streaming devices because those products do not work well with its own Prime Video service.

The move, which makes obvious sense in that the products from Apple and Google compete directly with Amazon's Fire TV devices, is also a head-scratcher in that the e-tailing giant has decided to end the sale of the popular items (Oct. 29) as it moves into the important Christmas selling season.

According to Parks Associates, nearly 20 percent of U.S. households with broadband own at least one video-streaming box, while eight percent own a stick. Among those same households, Roku devices are used most often (37 percent) followed by Google (19 percent), Apple (17 percent) and Amazon (14 percent).
 

From the article "Amazon dumps rival Apple and Google streaming devices" by George Anderson.

Previously In The News

Samsung Leads in 4K TV Sales, Report Shows

Parks reported that 19 percent of U.S. broadband households intend to purchase a flat-panel TV set by the end of 2015. Roughly 40 percent of those households are looking for a 4K TV set, which is appr...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...